#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Growth hormone deficiency Nasopharyngeal cancer Neoplasm Acute myeloid leukaemia refractory Cutaneous T-cell lymphoma stage I Myxofibrosarcoma Gestational trophoblastic tumour Extra-osseous Ewing's sarcoma metastatic Non-small cell lung cancer Thymic carcinoma Ovarian epithelial cancer Philadelphia positive acute lymphocytic leukaemia Dent's disease Salivary gland cancer Alpha-1 antitrypsin deficiency More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Trials in Disease Bronchiolitis obliterans syndrome – Diagnostics Gaucher’s disease type I – Life with Disease Congenital nephrogenic diabetes insipidus – Treatment Angiosarcoma metastatic X-linked lymphoproliferative syndrome Marfan’s syndrome – Diagnostics Hereditary optic atrophy – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency VEXAS syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olmesartan Medoxomil Plasma HYPOCHLOROUS ACID Streptococcus Pneumoniae Mva-209-Fsp-B1 Dabigatran Etexilate ADX-324 SIGVOTATUG VEDOTIN Piperacillin Sodium Pyruvic Acid Salbutamol Sulfate Ph. Eur. Tegafur Tapentadol Hydrochloride Acetylcysteine Co-Trimoxazole Kpl-404 Relacorilant Dorzolamide LUMC-BOB1-B7-TCR.1 Vancomycin Hydrochloride More therapies…

    Learn about Your Condition

    Primary hyperoxaluria Hepatobiliary cancer Knee arthroplasty Rectal cancer stage II Infection Cervical dysplasia Arterial disorder Lung adenocarcinoma stage III Cardiovascular disorder Colorectal cancer stage IV Sickle cell disease Procedural hypotension Coronary artery dissection Trisomy 21 Osteomyelitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Topical Chloramphenicol vs Topical Ciprofloxacin for Treating Otorrhea in Adults with Chronic Suppurative Otitis Media

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin
    Spain

  • Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Thiamine Hydrochloride
    Denmark

  • Phase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Tremelimumab
    • Durvalumab
    • Lenvatinib
    Italy

  • Safety and early efficacy of TranspoCART19 CAR‑T CD19 therapy in patients with refractory lupus nephritis (Phase I‑IIa)

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Transpocart19
    Spain

  • Study of denikitug alone or with drug combination in adults with HER2‑negative metastatic gastric, gastroesophageal junction and esophageal adenocarcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Ramucirumab
    • Nivolumab
    • Paclitaxel Albumin-Bound
    France Spain

  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Colitis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Belgium Germany Hungary Italy Poland
Previous Page
1 … 695 696 697 698 699 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!